Palvella Therapeutics (PVLA) Interest & Investment Income (2017 - 2024)
Historic Interest & Investment Income for Palvella Therapeutics (PVLA) over the last 9 years, with Q3 2024 value amounting to $169000.0.
- Palvella Therapeutics' Interest & Investment Income fell 6921.68% to $169000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.1 million, marking a year-over-year decrease of 3903.84%. This contributed to the annual value of $1.9 million for FY2023, which is 15672.68% up from last year.
- Palvella Therapeutics' Interest & Investment Income amounted to $169000.0 in Q3 2024, which was down 6921.68% from $201000.0 recorded in Q2 2024.
- Over the past 5 years, Palvella Therapeutics' Interest & Investment Income peaked at $549000.0 during Q3 2023, and registered a low of -$6000.0 during Q4 2021.
- In the last 5 years, Palvella Therapeutics' Interest & Investment Income had a median value of $169000.0 in 2024 and averaged $194578.9.
- Per our database at Business Quant, Palvella Therapeutics' Interest & Investment Income crashed by 20000.0% in 2022 and then soared by 1200000.0% in 2023.
- Over the past 5 years, Palvella Therapeutics' Interest & Investment Income (Quarter) stood at $8000.0 in 2020, then plummeted by 175.0% to -$6000.0 in 2021, then soared by 5950.0% to $351000.0 in 2022, then rose by 29.63% to $455000.0 in 2023, then plummeted by 62.86% to $169000.0 in 2024.
- Its last three reported values are $169000.0 in Q3 2024, $201000.0 for Q2 2024, and $240000.0 during Q1 2024.